BioPosture: Septuagenarian entrepreneurs bounce back
By GREGORY ZELLER // From the Going in Style File comes Sleep BioLogics Inc., a startup from two 70-something entrepreneurs who wouldn’t take retirement lying down. Actually, Sleep BioLogics is…
FDA
Alessi: LI must work together on a 5G future
By MARC ALESSI // It’s no secret that Long Island has problems with cellphone service. More than 200 cellphone “dead zones” were identified in late 2016, as well as poor-quality…
For food manufacturers, MTRC/LIFC spells “growth”
By GREGORY ZELLER // Some fairly thick alphabet soup will create a tasty economic-development stew for regional food manufacturers. The Manufacturing & Technology Resource Consortium is partnering with the Port…
Concussion-focused Scythian sets market debut
By GREGORY ZELLER // Scythian Biosciences Corp. is going public. The New York City/Toronto-based biotech, led by Great Neck investment banker Jonathan Gilbert on its quest to develop the world’s…
FDA has a date for stem cells hearing
The Food and Drug Administration has rescheduled a critical public hearing on potential regulations for the burgeoning stem cell industry. “Request for Comments – Draft Guidances Relating to the Regulation…
FDA pushes off stem cell hearing
The Food and Drug Administration has indefinitely postponed a public hearing on stem cell regulation due to what it called “considerable interest.” “Due to this interest, and to give stakeholders…